These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32192377)

  • 21. Current status and future prospects of multi-antigen tick vaccine.
    Parthasarathi BC; Kumar B; Ghosh S
    J Vector Borne Dis; 2021; 58(3):183-192. PubMed ID: 35170454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
    Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of Ixodes ricinus and Dermacentor reticulatus tick infestations in rabbits vaccinated with the Q38 Subolesin/Akirin chimera.
    Contreras M; de la Fuente J
    Vaccine; 2016 Jun; 34(27):3010-3013. PubMed ID: 27154388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.
    Kortekaas J; Vloet RP; McAuley AJ; Shen X; Bosch BJ; de Vries L; Moormann RJ; Bente DA
    Vector Borne Zoonotic Dis; 2015 Dec; 15(12):759-64. PubMed ID: 26684523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Vaccination With a Formulation Combining
    Contreras M; Kasaija PD; Merino O; de la Cruz-Hernandez NI; Gortazar C; de la Fuente J
    Front Cell Infect Microbiol; 2019; 9():45. PubMed ID: 30881925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of climate change on risk of incursion of Crimean-Congo haemorrhagic fever virus in livestock in Europe through migratory birds.
    Gale P; Stephenson B; Brouwer A; Martinez M; de la Torre A; Bosch J; Foley-Fisher M; Bonilauri P; Lindström A; Ulrich RG; de Vos CJ; Scremin M; Liu Z; Kelly L; Muñoz MJ
    J Appl Microbiol; 2012 Feb; 112(2):246-57. PubMed ID: 22118269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of Human Dermal Dendritic Cells and Langerhans Cells Treated with
    Rodriguez SE; McAuley AJ; Gargili A; Bente DA
    Viruses; 2018 Jul; 10(7):. PubMed ID: 30036960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology of the tick-host interaction and the control of ticks and tick-borne diseases.
    Willadsen P; Jongejan F
    Parasitol Today; 1999 Jul; 15(7):258-62. PubMed ID: 10377526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guineafowl, ticks and Crimean-Congo hemorrhagic fever in Turkey: the perfect storm?
    Sekercioğlu CH
    Trends Parasitol; 2013 Jan; 29(1):1-2. PubMed ID: 23206535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for vaccination against the ticks of pets and the potential impact on pathogen transmission.
    de la Fuente J; Villar M; Contreras M; Moreno-Cid JA; Merino O; Pérez de la Lastra JM; de la Fuente G; Galindo RC
    Vet Parasitol; 2015 Feb; 208(1-2):26-9. PubMed ID: 25555312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice.
    Leventhal SS; Meade-White K; Shaia C; Tipih T; Lewis M; Mihalakakos EA; Hinkley T; Khandhar AP; Erasmus JH; Feldmann H; Hawman DW
    EBioMedicine; 2024 Mar; 101():105017. PubMed ID: 38382314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of protein glycosylation in development of novel tick vaccine strategies.
    de la Fuente J; Canales M; Kocan KM
    Parasite Immunol; 2006 Dec; 28(12):687-8. PubMed ID: 17096649
    [No Abstract]   [Full Text] [Related]  

  • 36. Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogens.
    de la Fuente J; Moreno-Cid JA; Galindo RC; Almazan C; Kocan KM; Merino O; Perez de la Lastra JM; Estrada-Peña A; Blouin EF
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():172-8. PubMed ID: 24589118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in research on Crimean-Congo hemorrhagic fever.
    Papa A; Mirazimi A; Köksal I; Estrada-Pena A; Feldmann H
    J Clin Virol; 2015 Mar; 64():137-43. PubMed ID: 25453328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current situation of Crimean-Congo hemorrhagic fever in Southeastern Europe and neighboring countries: a public health risk for the European Union?
    Dreshaj S; Ahmeti S; Ramadani N; Dreshaj G; Humolli I; Dedushaj I
    Travel Med Infect Dis; 2016; 14(2):81-91. PubMed ID: 27044611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innovative approaches for the control of ticks and tick-borne diseases.
    de la Fuente J; Mazuecos L; Contreras M
    Ticks Tick Borne Dis; 2023 Nov; 14(6):102227. PubMed ID: 37419001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tick vaccines.
    Willadsen P
    Parasitology; 2004; 129 Suppl():S367-87. PubMed ID: 15938519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.